Overview

Venetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Status:
Not yet recruiting
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
This is an open-label phase I study designed to evaluate the safety of venetoclax-navitoclax with cladribine-based salvage therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Medical College of Wisconsin
Treatments:
Cladribine
Cytarabine
Lenograstim
Mitoxantrone
Navitoclax
Venetoclax